Chris Tanner
Supervisory Board member
Health care
CureVac
Germany
Biography
Chris Tanner is Chief Financial Officer and Head of Investor Relations of Cassiopea since 2015. Since 2006 he has been a Board Member and CFO of Cosmo Pharmaceuticals SpA now SA. He is also a member of the board of directors or advisory board (Beirat) of DKSH AG (SIX: DKSH), Private Equity Holding AG (SIX: PEH), Qvanteq AG and Joimax GmbH. From 1998 to 2001 he was a partner of Dr. Ernst Mueller-Moehl and co-founder of the 20 Minutes group of newspapers, founded A&A Active Investor, a SIX listed investment company. From 1992 to 1998 he was the head of corporate finance & capital markets of UBS in Zurich and from 1976 to 1991 he had various functions in the Corporate Banking Department of UBS in Zurich, Madrid and Los Angeles. Dr. Tanner has a PhD in economics and diploma as an economist from the University of St. Gallen. None of the companies where Chris Tanner has a management or board position major shareholder of has any business activities with CureVac.
Research Interest
Finance
